Boston Scientific

YTD

ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO

Michael F. Mahoney

CEOMichael F. Mahoney

Employees

59,000

Employees59,000

Headquarters

Marlborough, Massachusetts

HeadquartersMarlborough, Massachusetts

Founded

1979

Founded1979

Employees

59,000

Employees59,000

BSX Key Statistics

Market cap

64.74B

Market cap64.74B

Price-Earnings ratio

18.71

Price-Earnings ratio18.71

Dividend yield

—

Dividend yield—

Average volume

15.59M

Average volume15.59M

High today

$43.68

High today$43.68

Low today

$42.50

Low today$42.50

Open price

$42.73

Open price$42.73

Volume

13.46M

Volume13.46M

52 Week high

$109.50

52 Week high$109.50

52 Week low

$42.20

52 Week low$42.20

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $43.56. The company's market cap stands at 64.74B, with a P/E ratio of 18.71.

On 2026-07-23, Boston Scientific(BSX) stock moved within a range of $42.50 to $43.68. With shares now at $43.56, the stock is trading +2.5% above its intraday low and -0.3% below the session's peak.

Trading volume for Boston Scientific(BSX) stock has reached 13.46M, versus its average volume of 15.59M.

The stock's 52-week range extends from a low of $42.20 to a high of $109.50.

BSX News

Nasdaq 5h

September 4th Options Now Available For Boston Scientific

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options become available today, for the September 4th expiration. At Stock Options Channel , our Yiel...

Simply Wall St 9h

Boston Scientific Starts Global Faraflex Trial With First Atrial Fibrillation Patient

Boston Scientific (NYSE:BSX) has enrolled the first patient in the FARADIGM global IDE trial for its Faraflex pulsed field ablation catheter. The FARADIGM stud...

Simply Wall St 1d

Boston Scientific Stock Looks Below Fair Value Even As Returns Stay Weak

Boston Scientific stock is coming off a difficult stretch, with the share price down 58.1% over the past year, yet the broader valuation checks still lean towar...

Analyst ratings

87%

of 31 ratings

Buy

87.1%

Hold

12.9%

Sell

More BSX News

Simply Wall St 5d

The Bull Case For Boston Scientific Could Change Following Global Recall Of CRE Endoscopy Devices

In May 2026, Boston Scientific voluntarily began recalling multiple CRE and CRE Pro Wireguided endoscopy devices worldwide, after identifying potential sterile...

Simply Wall St 6d

Boston Scientific Recalls Endoscopy Devices, Is The Stock A Bargain?

Boston Scientific (BSX) is under scrutiny after a series of voluntary Class II recalls of its CRE and CRE Pro Wireguided endoscopy devices, prompted by potentia...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.